Craig Conway
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Paylocity Marketplace Debut Reshapes EasySource Investment Story. EasySource's launch of a Paylocity marketplace has altered its investment narrative, highlighting growing ecosystem integration. Meanwhile, analysts continue to view Paylocity as a quality stock with strong cash flow and high return on invested capital. The company trades at a trailing P/E of 28.4, with an average analyst target of $172.20.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Nutanix Stock Underperforms Market Amid Broker Analysis. Nutanix shares have recently declined more sharply than the broader market, drawing attention from financial analysts. Recent broker reports suggest the stock is a focus for investment strategies, while comparisons with peers like MongoDB and Google highlight its position among value-oriented tech names. The company's trailing P/E of 12.7 and average analyst target of $77.79 provide context for these ongoing discussions.
Transaction History
| CRM | ▼ Sell | Open Market | 1,418 | $369K | 9/4/2026 | View on chart |
| CRM | ▼ Sell | Open Market | 3,082 | $803K | 9/4/2026 | View on chart |
| PCTY | ▼ Sell | Open Market | 3,145 | $493K | 8/27/2026 | View on chart |
| CRM | ▲ Buy | Option Exercise | 441 | $0 | 8/22/2026 | View on chart |
| PCTY | ▲ Buy | Grant | 2,207 | $0 | 8/14/2026 | View on chart |
| CRM | ▲ Buy | Option Exercise | 442 | $0 | 5/22/2026 | View on chart |
| CRM | ▲ Buy | Option Exercise | 442 | $0 | 2/22/2026 | View on chart |
| NTNX | ▲ Buy | Grant | 4,588 | $0 | 12/12/2025 | View on chart |
| CRM | ▲ Buy | Option Exercise | 274 | $0 | 11/22/2025 | View on chart |
| CRM | ▲ Buy | Option Exercise | 274 | $0 | 8/22/2025 | View on chart |
| PCTY | ▲ Buy | Grant | 1,261 | $0 | 8/15/2025 | View on chart |
| CRM | ▲ Buy | Option Exercise | 274 | $0 | 5/22/2025 | View on chart |
| CRM | ▲ Buy | Option Exercise | 275 | $0 | 2/22/2025 | View on chart |
| NTNX | ▲ Buy | Grant | 3,646 | $0 | 12/13/2024 | View on chart |
| CRM | ▲ Buy | Option Exercise | 330 | $0 | 11/22/2024 | View on chart |
| CRM | ▲ Buy | Option Exercise | 330 | $0 | 8/22/2024 | View on chart |
| PCTY | ▲ Buy | Grant | 1,338 | $0 | 8/15/2024 | View on chart |
| CRM | ▼ Sell | Open Market | 5,323 | $1.3M | 6/11/2024 | View on chart |
| CRM | ▼ Sell | Open Market | 677 | $160K | 6/11/2024 | View on chart |
| CRM | ▲ Buy | Option Exercise | 330 | $0 | 5/22/2024 | View on chart |
| PCTY | ▲ Buy | Grant | 546 | $0 | 3/1/2024 | View on chart |
| CRM | ▲ Buy | Option Exercise | 331 | $0 | 2/22/2024 | View on chart |
| NTNX | ▲ Buy | Grant | 6,088 | $0 | 12/8/2023 | View on chart |
| CRM | ▲ Buy | Option Exercise | 535 | $0 | 11/22/2023 | View on chart |
| CRM | ▲ Buy | Option Exercise | 535 | $0 | 8/22/2023 | View on chart |
| NTNX | ▼ Sell | Open Market | 25,000 | $760K | 12/20/2022 | View on chart |
| NTNX | ▲ Buy | Grant | 8,682 | $0 | 12/9/2022 | View on chart |
| NTNX | ▲ Buy | Grant | 7,365 | $0 | 12/10/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Salesforce Shares Fall More Than Market Amid AI Valuation Concerns
Salesforce’s stock declined more sharply than the broader market on the day the Nasdaq ended its four‑week rally, as tech shares sold off. The drop came after the company’s recent AI integration deals prompted analysts to reassess its valuation. The broader market weakness was reflected in a Dow Jones session where CRM was listed among the laggards. These factors combine to put pressure on the share price near its $182 support level.
Salesforce Shares Fall More Than Market Amid AI Valuation Concerns. Salesforce’s stock declined more sharply than the broader market on the day the Nasdaq ended its four‑week rally, as tech shares sold off. The drop came after the company’s recent AI integration deals prompted analysts to reassess its valuation. The broader market weakness was reflected in a Dow Jones session where CRM was listed among the laggards. These factors combine to put pressure on the share price near its $182 support level.